Isofol Medical AB's market cap is currently €20.47M. The company's EPS TTM is €-0.008322587; its P/E ratio is ―; Isofol Medical AB is scheduled to report earnings on August 26, 2025, and the estimated EPS forecast is €―. See an overview of income statement, balance sheet, and cash flow financials.
